GleamWall
中文EN

OABI OmniAb, Inc.

Services-Commercial Physical & Biological Research · Nasdaq · SEC CIK 1846253 · Fiscal year ends 12/31

Financial factors as of 2026-09-30 (2026Q3), TTM = sum of the last four quarters

Growth

TTM revenue YoY90.6%
TTM net income YoY31.7%
TTM EPS YoY42.4%
Revenue 3-yr CAGR-14.7%
Net income 3-yr CAGR—

Margins

Gross margin—
Operating margin-115.9%
Net margin-108.1%
FCF margin5.9%
EBITDA margin-64.2%

Returns

ROE-16.5%
ROA-14.5%
ROIC (approx.)-15.5%
Asset turnover0.13x

Leverage & solvency

Liabilities / assets14.4%
Debt / equity0.00x
Current ratio4.21x
Interest coverage—

Cash quality & payout

Operating cash flow / net income-0.06x
Accruals ratio-15.4%
Payout ratio—
Capex / revenue0.7%

Factor history charts and full statement history on Pro 🔒

Financial statements

Line item 2026Q32026-09-302026Q22026-06-302026Q12026-03-312025Q4*2025-12-312025Q32025-09-302025Q22025-06-302025Q12025-03-312024Q4*2024-12-31
Income statement
Revenue$3.99M$13.41M$14.43M$8.38M$2.24M$3.90M$4.15M$10.80M
R&D expense$9.55M$9.59M$9.64M$13.91M$10.38M$10.86M$12.60M$13.31M
SG&A expense$7.24M$6.65M$6.62M$6.84M$6.78M$7.68M$7.92M$7.36M
Operating income-$16.37M-$6.64M-$7.83M-$15.77M-$18.14M-$16.22M-$18.84M-$15.88M
Pretax income-$15.86M-$6.21M-$7.26M-$14.55M-$17.69M-$15.76M-$18.31M-$15.22M
Income tax-$127,000-$353,000$442,000-$367,000-$1.16M$119,000-$106,000-$2.15M
Net income-$15.73M-$5.86M-$7.71M-$14.18M-$16.52M-$15.88M-$18.20M-$13.07M
EBITDA-$15.87M-$6.04M-$7.22M$3.30M-$17.24M-$15.42M-$17.88M-$8.27M
EPS (basic)-0.12-0.05-0.06—-0.14-0.15-0.17—
EPS (diluted)-0.12-0.05-0.06—-0.14-0.15-0.17—
Weighted avg. shares (diluted)129.29M128.79M128.25M—114.73M106.15M105.62M—
Balance sheet
Cash & equivalents$22.88M$24.34M$29.05M$25.52M$29.10M$18.84M$11.45M$28.16M
Short-term investments$41.33M$27.66M$20.03M$28.50M$30.96M$23.33M$32.70M$31.84M
Receivables$2.57M$10.33M$12.64M$7.39M$3.10M$2.71M$6.48M$5.27M
Inventory$1.07M$1.01M$920,000$823,000$443,000$316,000—$48,000
Current assets$70.98M$66.01M$65.12M$65.34M$66.35M$47.62M$53.58M$68.14M
PP&E, net$7.94M$8.47M$9.02M$9.43M$13.28M$14.06M$14.71M$15.49M
Goodwill$83.98M$83.98M$83.98M$83.98M$83.98M$83.98M$83.98M$83.98M
Intangibles$113.02M$116.07M$119.12M$125.15M$128.38M$131.60M$134.83M$138.06M
Total assets$290.92M$290.26M$293.65M$300.91M$309.69M$295.67M$306.18M$325.56M
Current liabilities$16.85M$13.76M$13.57M$16.25M$13.28M$12.64M$11.41M$15.09M
Total liabilities$41.76M$29.98M$31.00M$33.89M$32.25M$33.61M$32.67M$37.94M
Shareholders' equity$249.16M$260.27M$262.65M$267.03M$277.44M$262.06M$273.52M$287.62M
Shares outstanding145.86M145.39M144.78M144.31M143.96M122.70M122.13M121.60M
Cash flow statement
Operating cash flow$10.57M$2.68M-$4.91M-$5.67M-$9.76M-$5.15M-$15.87M-$3.87M
Capital expenditure$0$110,000$167,000$9,000$182,000$165,000$209,000$46,000
Free cash flow$10.57M$2.57M-$5.08M-$5.68M-$9.95M-$5.31M-$16.08M-$3.92M
Investing cash flow-$13.49M-$7.62M$8.44M$2.71M-$7.67M$12.30M-$878,000$385,000
Financing cash flow$1.46M$233,000$0-$50,000$27.68M$236,000$44,000$3.85M
Depreciation & amortization$500,000$600,000$606,000$19.06M$900,000$800,000$966,000$7.61M
Stock-based compensation$3.06M$3.16M$3.34M$3.61M$3.96M$4.11M$4.14M$5.12M

Free plan shows the latest 8 periods; Pro shows all 21 🔒

· This company does not report gross profit in XBRL.

· Most companies do not report Q4 separately: Q4 = full year − first three quarters (marked *). EPS and share counts cannot be subtracted, so Q4 EPS is often blank; cash flow statements are year-to-date in quarterly reports, so single quarters are mostly derived.

· No price-based ratios such as P/E or P/B (the site uses no licensed market data). Blanks are shown as —.

Source: SEC EDGAR XBRL (financial statements filed with the SEC), updated 2026-11-21 06:27.